NCT03058263View on ClinicalTrials.gov

Effect of Neostigmine on the Recovery of Rocuronium: A Comparison Between Partial and TOF Ratio-Based Dose

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

February 1, 2017

Study Completion Date

February 28, 2017

Conditions
Muscle RelaxantGeneral Anesthesia
Interventions
DRUG

Dose of Neostigmine

Subjects were given partial dose of neostigmine as rocuronium reversal after the surgery had finished; subjects were given TOF ratio-based dose of neostigmine after the surgery had finished

Trial Locations (1)

10430

Cipto Mangunkusumo Cental National Hospital, Jakarta

All Listed Sponsors
lead

Indonesia University

OTHER

NCT03058263 - Effect of Neostigmine on the Recovery of Rocuronium: A Comparison Between Partial and TOF Ratio-Based Dose | Biotech Hunter | Biotech Hunter